Volume 87, Issue 2, 2022-8-1, Pages A9-e90
Articles in this issue:
1. Editorial board
2. Table of contents
- Pages A12-A12, A14-A14, A16-A16, A19-A21, A26-A26, A28-A28, A30-A30, A32-A32, A41-A42, A44-A44.
- PDF
3. Information for readers
4. JAAD Case Reports article list
- Pages A48-A48, A58-A58, A60-A60.
- PDF
5. Journal based CME instructions and information
6. Skin cancer: Primary, secondary, and tertiary prevention. Part I
- Pages 255-268.
- Perez, Mariana, BA, Abisaad, Juanita Arango, MD, Rojas, Kristina D., BS, Marchetti, Michael A., MD, and Jaimes, Natalia, MD.
- PDF
7. Skin cancer: Primary, secondary, and tertiary prevention. Part II.
- Pages 271-288.
- Rojas, Kristina D., BS, Perez, Mariana E., BA, Marchetti, Michael A., MD, Nichols, Anna J., MD, PhD, Penedo, Frank J., PhD, and Jaimes, Natalia, MD.
- PDF
8. Letter from the editor: Meta-analysis models
- Pages 291-292.
- Elston, Dirk M., MD.
- PDF
9. This Month in JAAD: August 2022
- Pages 293-293.
- Elston, Dirk M., MD.
- PDF
10. This Month in JAAD Case Reports: August 2022
- Pages 294-294.
- Sloan, Brett, MD.
- PDF
11. This Month in JAAD International: August 2022: Cutaneous reactions to COVID-19 messenger RNA booster dose vaccination
- Pages 295-295.
- Kantor, Jonathan, MD, MSCE.
- PDF
12. Pediatric longitudinal melanonychia: Delaying the bottom line
- Pages 296-297.
- Heymann, Warren R., MD.
- PDF
13. The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness)
- Pages 298-305.
- El Sharouni, Mary-Ann, MD, Rawson, Robert V., MBBS, Sigurdsson, Vigfús, MD, Witkamp, Arjen J., MD, van Gils, Carla H., PhD, Scolyer, Richard A., MD, Thompson, John F., MD, van Diest, Paul J., MD, and Lo, Serigne N., PhD.
- PDF
14. Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata
- Pages 306-313.
- King, Brett, MD, PhD, Mesinkovska, Natasha, MD, PhD, Mirmirani, Paradi, MD, Bruce, Suzanne, MD, Kempers, Steve, MD, Guttman-Yassky, Emma, MD, PhD, Roberts, Janet L., MD, McMichael, Amy, MD, Colavincenzo, Maria, MD, Hamilton, Colleen, MS, Braman, Virginia, BS, and Cassella, James V., PhD.
- PDF
15. Adult atopic eczema and the risk of dementia: A population-based cohort study
- Pages 314-322.
- Magyari, Alexa, MS, Ye, Morgan, MPH, Margolis, David J., MD, PhD, McCulloch, Charles E., PhD, Cummings, Steven R., MD, Yaffe, Kristine, MD, Langan, Sinéad M., FRCP, PhD, and Abuabara, Katrina, MD, MA, MSCE.
- PDF
16. Prevalence and factors associated with long-term remission in cutaneous lupus: A longitudinal cohort study of 141 cases
- Pages 323-332.
- Fayard, Damien, MD, Francès, Camille, MD, Amoura, Zahir, MD, MSc, Breillat, Paul, MD, Mathian, Alexis, MD, PhD, Senet, Patricia, MD, Barbaud, Annick, MD, PhD, Arnaud, Laurent, MD, PhD, and Chasset, François, MD, PhD.
- PDF
17. Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study
- Pages 333-342.
- Tehlirian, Christopher, MD, MBA, Singh, Ravi Shankar P., PhD, Pradhan, Vivek, MS, Roberts, Erika S., BS, Tarabar, Sanela, MD, MPH, Peeva, Elena, MD, Vincent, Michael S., MD, and Gale, Jeremy D., PhD.
- PDF
18. Associations of combined lifestyle and genetic risks with incident psoriasis: A prospective cohort study among UK Biobank participants of European ancestry
- Pages 343-350.
- Shen, Minxue, PhD, Xiao, Yi, PhD, Jing, Danrong, MD, Zhang, Guanxiong, PhD, Su, Juan, PhD, Lin, Shuhong, PhD, Chen, Xiang, PhD, and Liu, Hong, PhD.
- PDF
19. Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
- Pages 351-358.
- Shi, Vivian Y., MD, Bhutani, Tina, MD, Fonacier, Luz, MD, Deleuran, Mette, MD, Shumack, Stephen, FACD, Valdez, Hernan, MD, Zhang, Fan, PhD, Chan, Gary L., PharmD, Cameron, Michael C., MD, and Yin, Natalie C., MD.
- PDF
20. Bullous pemphigoid: Three main clusters defining 3 outcome profiles
- Pages 359-365.
- Guerrois, Florine, MD, Hassan, Elsa, MD, Bettuzzi, Thomas, MD, Seta, Vannina, MD, Goulvestre, Claire, MD, Jelti, Lamia, MD, Belmondo, Thibaut, MD, Wolkenstein, Pierre, MD, PhD, Aractingi, Selim, MD, PhD, Ingen-Housz-Oro, Saskia, MD, and Dupin, Nicolas, MD.
- PDF
21. Clinical features and natural course of pediatric longitudinal melanonychia: A retrospective cohort study in Korea
- Pages 366-372.
- Lee, Ji Su, MD, Kim, Sungbum, MD, Kim, Dong Hyo, MD, Lee, Ji Won, MD, Mun, Je-Ho, MD, PhD, and Lee, Si-Hyung, MD, PhD.
- PDF
22. Focused update: Guidelines of care for the management of actinic keratosis
- Pages 373-374.e5.
- Eisen, Daniel B., MD (Chair), Dellavalle, Robert P., MD, PhD, MSPH, Frazer-Green, Lindsy, PhD, Schlesinger, Todd E., MD, Shive, Melissa, MD, MPH, and Wu, Peggy A., MD, MPH.
- PDF
23. Assessing signs of torture: A review of clinical forensic dermatology
- Pages 375-380.
- Deps, Patrícia D., MD, PhD, Aborghetti, Hugo Pessotti, Zambon, Taís Loureiro, Costa, Victória Coutinho, dos Santos, Julienne Dadalto, Collin, Simon M., PhD, and Charlier, Philippe, MD.
- PDF
24. Antihistamine safety in older adult dermatologic patients
- Pages 381-386.
- Grinnell, Madison, BA, Price, Kyla N., BS, Shah, Amit, MD, and Butler, Daniel C., MD.
- PDF
25. Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy
- Pages 387-389.
- Ahad, Tashmeeta, BM BCh, MA(Cantab), MRCP, Wang, Elle Yueqiao, Msc, Liu, Yi A., MD, Lee, Tim K., PhD, Lui, Harvey, MD, FRCPC, Crawford, Richard I., MD, and Kalia, Sunil, MD, MHSc, FRCPC.
- PDF
26. Placebo group regrowth rate in alopecia areata clinical trials: A systematic review and meta-analysis
- Pages 389-390.
- Han, Jane J., BS, Desai, Sheena, BS, Li, Sara J., BS, Lee, Karen J., BS, Mita, Carol, MLIS, Joyce, Cara, PhD, and Mostaghimi, Arash, MD, MPA, MPH.
- PDF
27. Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Pages 390-393.
- Peeva, Elena, MD, Guttman-Yassky, Emma, MD, Banerjee, Anindita, PhD, Sinclair, Rodney, MD, Cox, Lori Ann, DO, Zhu, Linda, MD, PhD, Zhu, Hua, PhD, Vincent, Michael, MD, PhD, and King, Brett, MD, PhD.
- PDF
28. From the Cochrane Library: Systemic treatments for eczema, a network meta-analysis
- Pages 393-395.
- Guo, Sarah, BA, Donaldson, Marie, MD, Ortega-Loayza, Alex G., MD, MCR, Sawangjit, Ratree, PhD, Chaiyakunapruk, Nathorn, PharmD, PhD, and Adler, Brandon L., MD.
- PDF
29. The association between frontal fibrosing alopecia, sunscreen, and moisturizers: A systematic review and meta-analysis
- Pages 395-396.
- Maghfour, Jalal, MD, Ceresnie, Marissa, DO, Olson, Justin, BS, and Lim, Henry W., MD.
- PDF
30. Randomized clinical trial of low-dose oral minoxidil for the treatment of female pattern hair loss: 0.25 mg versus 1 mg
- Pages 396-399.
- Nascimento e Silva, Marcella, MD, MSc, Ramos, Paulo Müller, MD, PhD, Silva, Márcio Roberto, PhD, Nascimento e Silva, Rafaella, MD, PhD, and Barbosa Raposo, Nádia Rezende, MSc, PhD.
- PDF
31. Treatment of immune checkpoint inhibitor–mediated psoriasis: A systematic review
- Pages 399-400.
- Said, Jordan Taylor, BA, Elman, Scott Andrew, MD, Perez-Chada, Lourdes Maria, MD, Mita, Carol, MLIS, Merola, Joseph F., MD, MMSc, and LeBoeuf, Nicole R., MD, MPH.
- PDF
32. Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: A case series
- Pages 400-403.
- Ju, Teresa, BS, Labib, Angelina, BS, Vander Does, Ashley, BA, and Yosipovitch, Gil, MD.
- PDF
33. Female sex is associated with higher rates of dermatologic adverse events among patients with melanoma receiving immune checkpoint inhibitor therapy: A retrospective cohort study
- Pages 403-406.
- Bui, Ai-Tram N., MD, Bougrine, Amina, MD, Buchbinder, Elizabeth I., MD, Giobbie-Hurder, Anita, MS, and LeBoeuf, Nicole R., MD, MPH.
- PDF
34. No increased incidence of Clostridium difficile infection among patients with hidradenitis suppurativa treated with systemic clindamycin
- Pages 406-407.
- Kwak, Ruby, BS, Lopez, Christina G., BS, Noe, Megan H., MD, MPH, MSCE, Nambudiri, Vinod E., MD, MBA, and Charrow, Alexandra P., MD, MBE.
- PDF
35. Topical sirolimus therapy for nevus sebaceus and epidermal nevus: A case series
- Pages 407-409.
- Zhou, Amanda G., BS, and Antaya, Richard J., MD.
- PDF
36. Association between topical corticosteroid use and fracture risk among pediatric patients with atopic dermatitis
- Pages 409-411.
- Imhof, Reese L., MD, Weaver, Amy L., MS, St. Sauver, Jennifer, PhD, Hand, Jennifer, MD, Davis, Dawn Marie R., MD, and Tollefson, Megha M., MD.
- PDF
37. Disparities in availability of skin therapies found in public assistance formularies
- Pages 411-417.
- Kamara, Michael, BA, Kuo, Alyce M., BS, Stein, Sarah L., MD, Faith, Esteban Fernandez, MD, Pelletier, Janice L., MD, Jacob, Sharon, MD, Gonzalez, Mercedes E., MD, and Silverberg, Nanette B., MD.
- PDF
38. Preliminary definition of flare in cutaneous lupus erythematosus using the Cutaneous Lupus Erythematosus Disease Area and Severity Index
- Pages 418-419.
- Keyes, Emily, BA, Borucki, Robert, MD, Feng, Rui, PhD, Grinnell, Madison, BA, Vazquez, Thomas, BS, Diaz, DeAnna, MS, MBS, and Werth, Victoria P., MD.
- PDF
39. Comparative efficacy of intralesional Candida antigen, intralesional bivalent human papilloma virus vaccine, and cryotherapy in the treatment of common warts
- Pages 419-421.
- Nassar, Amany, MD, Alakad, Rania, MD, Essam, Reham, MD, Bakr, Noha M., MD, and Nofal, Ahmad, MD.
- PDF
40. Utilization and outcomes of an asynchronous teledermatology pilot for an inpatient rehabilitation hospital
- Pages 421-423.
- Stephens, Michael R., MD, Das, Shinjita, MD, and Smith, Gideon P., MD, PhD, MPH.
- PDF
41. Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis
- Pages 423-425.
- Neale, Holly, BS, Michelon, Melissa, MD, Jacob, Susan, MD, Pinkston, Mary, MD, Ukaegbu, Rebecca, MD, Zamor, Waldo, MD, Morrison, Emily, MS, Deng, April, MD, PhD, and Levin, Nikki A., MD, PhD.
- PDF
42. Association of obesity in early childhood with atopic dermatitis in late childhood and adolescence
- Pages 426-427.
- Manjunath, Jaya, BS, and Silverberg, Jonathan I., MD, PhD, MPH.
- PDF
43. Incidence and comorbidities of pediatric alopecia areata: A retrospective matched cohort study using the Rochester Epidemiology Project
- Pages 427-429.
- Ali, Nora S., MD, Tollefson, Megha M., MD, Lohse, Christine M., MS, and Torgerson, Rochelle R., MD, PhD.
- PDF
44. Medical management of Stevens-Johnson syndrome/toxic epidermal necrolysis among North American dermatologists
- Pages 429-431.
- Han, Jane J., BS, Creadore, Andrew, BS, Seminario-Vidal, Lucia, MD, Micheletti, Robert, MD, Noe, Megan H., MD, MPH, MSCE, and Mostaghimi, Arash, MD, MPA, MPH.
- PDF
45. Synergistic effect of lymphovascular invasion and nodal involvement on prognosis in Merkel cell carcinoma: A retrospective analysis in the National Cancer Database
- Pages 432-433.
- Nguyen, Kevin A., MS, Maloney, Nolan J., MD, Yang, Jason J., MD, and Zaba, Lisa C., MD, PhD.
- PDF
46. Diagnostic yield of staging brain magnetic resonance imaging is low in Merkel cell carcinoma: A single-institution cohort study
- Pages 434-435.
- Saqlain, Farees, BA, Shalhout, Sophia Z., PhD, Emerick, Kevin S., MD, Kaufman, Howard L., MD, Chen, Yen-Lin E., MD, Cusack, James C., MD, Wright, Kayla, BA, and Miller, David Michael, MD, PhD.
- PDF
47. Mycophenolate mofetil versus methotrexate for vulvar lichen planus: A 10-year retrospective cohort study demonstrates comparable efficacy and tolerability
- Pages 436-438.
- Hrin, Matthew L., BA, Bowers, Nathan L., MD, PhD, Feldman, Steven R., MD, PhD, Huang, William W., MD, MPH, and Pichardo, Rita O., MD.
- PDF
48. Comparing antibiotic prescription rates between in-person and telemedicine visits
- Pages 438-440.
- Fathy, Ramie, AB, Briker, Sara, BS, Rodriguez, Olaf, MD, and Barbieri, John S., MD, MBA.
- PDF
49. Sunscreen use is not associated with increased blood concentrations of benzene among adults in the United States: Data from the National Health and Nutrition Examination Survey 2003-2006 and 2009-2018
- Pages 440-443.
- Chang, Michael S., BA, Moore, Kevin J., MD, MPH, Trepanowski, Nicole, BS, Koru-Sengul, Tulay, PhD, MHS, and Hartman, Rebecca I., MD, MPH.
- PDF
50. Topical sodium thiosulfate as treatment of calcinosis cutis: Case series and systematic review
- Pages 443-444.
- Ricardo, Jose W., MD, Sun, Helen Y., BSc (Med), Gorji, Mahdieh, MD, and Sebaratnam, Deshan F., MBBS (Hons).
- PDF
51. Risk factors for and prognostic impact of positive surgical margins after excision of Merkel cell carcinoma
- Pages 444-446.
- Maloney, Nolan J., MD, Nguyen, Kevin A., MS, So, Naomi A., MD, Aasi, Sumaira Z., MD, and Zaba, Lisa C., MD, PhD.
- PDF
52. Comparative responsiveness of cutaneous lupus erythematosus patients to methotrexate and mycophenolate mofetil: A cohort study
- Pages 447-448.
- Keyes, Emily, BA, Jobanputra, Anisha, BS, Feng, Rui, PhD, Grinnell, Madison, BA, Vazquez, Thomas, BS, Diaz, DeAnna, MS, MBS, and Werth, Victoria P., MD.
- PDF
53. Racial differences in psychiatric comorbidities of rosacea: A large, urban academic center case-control study
- Pages 448-451.
- Yi, Julie Z., BS, Pagani, Kyla, BS, Lukac, Danitza, MD, Li, Stephanie, BS, Chung, Hye Jin, MD, MMSc, and McGee, Jean S., MD, PhD.
- PDF
54. Patch testing results in skin of color: A retrospective review from the Massachusetts General Hospital contact dermatitis clinic
- Pages 452-454.
- Foschi, Cristina M., BS, Tam, Idy, MD, Schalock, Peter C., MD, and Yu, JiaDe, MD.
- PDF
55. Association of lichen planus with cardiovascular disease: A combined analysis of the UK Biobank and All of Us Study
- Pages 454-456.
- Leasure, Audrey C., BS, Acosta, Julian N., MD, Sansing, Lauren H., MD, MS, Sheth, Kevin N., MD, Cohen, Jeffrey M., MD, and Falcone, Guido J., MD, ScD, MPH.
- PDF
56. A novel proof-of-concept study assessing the lightening effects and safety of malassezin for treatment of facial hyperpigmentation
- Pages 456-458.
- Grimes, Pearl E., MD, Bhawan, Jag, MD, Howell, Michael D., PhD, Desai, Seemal, MD, Coryell, Edna, DC, Nashawati, Rama, MS, Einziger, Michael, BS, Simpson, Ann Marie, BS, Yaroshinsky, Alex, PhD, and Mc Craw, Tim, PhD.
- PDF
57. Common filaggrin gene loss-of-function variants are associated with skin cancer risk
- Pages 458-460.
- Adelanwa, Ayodele, MD, Yousaf, Ahmed, BA, Fang, Wei, PhD, and Kolodney, Michael S., MD, PhD.
- PDF
58. Distribution of race and Fitzpatrick skin types in data sets for deep learning in dermatology: A systematic review
- Pages 460-461.
- Kim, Yong-hun, BS, Kobic, Ajdin, MD, and Vidal, Nahid Y., MD.
- PDF
59. Isotretinoin use for acne in obese and overweight young people: A retrospective study
- Pages 461-464.
- Tallmadge, Maggie, BS, Patel, Ashaki, MD, Liegl, Melodee Nugent, MA, Pan, Amy, PhD, Barbeau, Jody, BS, and Lalor, Leah, MD.
- PDF
60. Disparities in pediatric clinical trials for acne vulgaris: A cross-sectional study
- Pages 464-466.
- Ding, Jeffrey, Haq, Ahmed Farhan, MB, BCh, BaO, MSc, Joseph, Marissa, MD, MSc, FRCPC, and Khosa, Faisal, MD, MBA, FFRRCSI, FRCPC.
- PDF
61. Mark, magnify, map: Improving biopsy-site photography
- Pages 467-469.
- Klufas, Daniel M., MD, Lohman, Mary E., MD, Liu, Jennifer Y., PhD, and Khodosh, Rita, MD, PhD.
- PDF
62. Spectrum of severe ocular complications following dupilumab exposure: A perspective from the ophthalmology clinic
- Pages 469-472.
- Ahn, Grace Sora, BS, Acuff, Kaela, BS, Sun, Bryan K., MD, PhD, and Baxter, Sally L., MD, MSc.
- PDF
63. Severe herpes simplex and varicella-zoster viral infection in patients with solid organ transplantation: A nationwide population-based cohort study with propensity score matching analysis
- Pages 472-474.
- Yu, Tung-Min, MD, Sun, Kuo-Ting, MD, Kung, Shiang-Cheng, MD, Lee, Brian K., MD, Wu, Ming-Ju, MD, Chen, Cheng-Hsu, MD, Sun, Chung-Shu, MD, Lo, Ying-Chih, MD, Lan, Tsuo-Hung, MD, Li, Chi-Yuan, MD, Chiu, Ting-Fang, MD, Lin, Mei-Chen, MSc, and Kao, Chia-Hung, MD.
- PDF
64. Atopic dermatitis and the risk of eating disorders: A population-based cohort study
- Pages 474-476.
- Kauppi, Saana, MD, Jokelainen, Jari, MSc, Timonen, Markku, MD, PhD, Tasanen, Kaisa, MD, PhD, and Huilaja, Laura, MD, PhD.
- PDF
65. Dermatologic findings in individuals with Turner syndrome: A cross-sectional study across the lifespan
- Pages 476-479.
- Said, Jordan Taylor, BA, Pithadia, Deeti J., MD, Snyder, Emma, BA, Elsharkawi, Ibrahim, MD, Lin, Angela, MD, and Lilly, Evelyn, MD.
- PDF
66. Lack of association between CDKN2A germline mutations and survival in patients with melanoma: A retrospective cohort study
- Pages 479-482.
- Ipenburg, Norbertus Anton, MD, El Sharouni, Mary-Ann, MD, van Doorn, Remco, MD, PhD, van Diest, Paul J., MD, PhD, van Leerdam, Monique E., MD, PhD, van der Rhee, Jasper I., MD, PhD, Goeman, Jelle, PhD, and Kukutsch, Nicole A., MD, PhD.
- PDF
67. Validation of International Classification of Diseases Tenth Revision code for prurigo nodularis
- Pages 482-484.
- Roh, Youkyung Sophie, BA, Marani, Melika, BS, Choi, Una, BA, Sutaria, Nishadh, BS, Parthasarathy, Varsha, BS, Deng, Junwen, BS, Bordeaux, Zachary A., BS, Taylor, Matthew T., BS, Semenov, Yevgeniy R., MD, and Kwatra, Shawn G., MD.
- PDF
68. Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review
- Pages 484-486.
- Sachdeva, Muskaan, BHSc, Rankin, Brian D., PhD, Mufti, Asfandyar, MD, Yeung, Jensen, MD, Vender, Ronald, MD, Luca, Nadia J., MD, Miettunen, Paivi, MD, Stevenson, Rebeka, MD, Devani, Alim R., MD, and Prajapati, Vimal H., MD.
- PDF
69. Diagnostic utility of preferentially expressed antigen in melanoma immunohistochemistry in the evaluation of melanomas with a co-existent nevoid melanocytic population: A single-center retrospective cohort study
- Pages 486-488.
- Farah, Maya, MD, and Chung, Hye Jin, MD, MMSc.
- PDF
70. Bicalutamide improves minoxidil-induced hypertrichosis in female pattern hair loss: A retrospective review of 35 patients
- Pages 488-490.
- Moussa, Anthony, MBBS, MS, Kazmi, Ahmed, MBChB, MRCP (UK), Bokhari, Laita, MPhil, and Sinclair, Rodney D., MBBS, MD, FACD.
- PDF
71. Propranolol response in patients with segmental versus focal facial hemangiomas: A retrospective case-control study
- Pages 490-491.
- Schmid, Florian, MD, and Hoeger, Peter H., MD.
- PDF
72. Dermatologic surgery opioid prescribing recommendations in practice
- Pages 492-494.
- Veerabagu, Surya A., BA, Yanes, Arianna F., MD, Cheng, Brian, BS, Etzkorn, Jeremy R., MD, MS, Miller, Christopher J., MD, Shin, Thuzar M., MD, PhD, Sobanko, Joseph F., MD, Higgins, H. William, MD, MBE, McMurray, Stacy L., MD, Walker, Joanna L., MD, and Giordano, Cerrene N., MD.
- PDF
73. From the Cochrane Library: Nonsurgical interventions for cutaneous Bowen disease
- Pages 494-495.
- Strock, Daniel M., BS, Militello, Michelle, MS, Sivesind, Torunn E., MD, Matin, Rubeta N., PhD, and Dellavalle, Robert P., MD, PhD, MSPH.
- PDF
74. The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis
- Pages 495-496.
- Chen, Jingsi, MD, Cheng, Jun, MD, Yang, Huan, MD, PhD, Tu, Wei, PhD, Zhang, Yan, MD, PhD, Luo, Xiaoyan, MD, PhD, and Wang, Hua, MD, PhD.
- PDF
75. Response to Falotico et al’s “Biotin beware: Perils of biotin supplementation”
- Pages 497-497.
- Nosewicz, Jacob, BS, Spaccarelli, Natalie, MD, Roberts, Kristen M., PhD, RDN, Hart, Phil A., MD, Kaffenberger, Jessica A., MD, Trinidad, John C., MD, MPH, and Kaffenberger, Benjamin H., MD, MS.
- PDF
76. Reply to: “Special editorial: When prescribing Janus Kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration’s September 1, 2021, data safety communication”
- Pages 498-499.
- King, Brett A., MD, PhD, and Craiglow, Brittany G., MD.
- PDF
77. Offering unsolicited cosmetic solutions during a routine medical dermatology visit: Ethical considerations
- Pages 500-501.
- Mosallaei, Daniel, BS, and Grant-Kels, Jane M., MD.
- PDF
78. Beyond JAAD July 2022
- Pages e55-e58.
- Bronin, Andrew, MD.
- PDF
79. Side lighting to enhance the visualization of leukotrichia in vitiligo
- Pages e59-e59.
- AlJasser, Mohammed I., MBBS, FRCPC.
- PDF
80. Use of overhead projector sheets for vulvar dermatoscopy
- Pages e61-e62.
- Rambhia, Sweta Hasmukh, MBBS, DVD, Malvankar, Dipali, MBBS, MD, DNB, MRCP, SCE, Rambhia, Kinjal Deepak, MBBS, MD, DNB, and Gulati, Amit, MBBS, DVD.
- PDF
81. The novel application of dropper cover for the protection of ampoules
- Pages e63-e64.
- Shao, Zhujun, BSN, Cao, Chunyan, BSN, Ma, Pengcheng, BPharm, and Li, Hongyang, PhD.
- PDF
82. Surgical field exposure of the back of the ear using adhesive strips to position the ear
- Pages e65-e66.
- Yue, Chao, MD, and Peng, Jian Zhong, MD.
- PDF
83. Disposable rubber gloves that are filled or inflated for prevention of pressure sores
- Pages e67-e68.
- Liu, Ruiqi, BSN, Zhao, Xiaodan, BSN, and Zhou, Xuan, BSN.
- PDF
84. Mechanical harvesting of perilesional normally pigmented tissue to merge donor and recipient sites for transplantation in vitiligo
- Pages e69-e70.
- Kachhawa, Dilip, MD, Kachhawa, Nripen, HSC, and Gupta, Somesh, MD.
- PDF
85. Pincer flap for reconstruction of the infraorbital medial aspect of the cheek
- Pages e71-e72.
- Portilla, Nataly, MD, Cerci, Felipe B., MD, MSc, and Tolkachjov, Stanislav N., MD.
- PDF
86. Precise volumetric quantification using 3D stereophotogrammetry in procedural and surgical dermatology
- Pages e73-e75.
- Wat, Heidi, MD, Kawa, Nisrine Imad, MD, Anderson, R. Rox, MD, and Avram, Mathew M., MD, JD.
- PDF
87. Sleep disturbances in older adults with pruritic eruptions: Implications across inconsistent literature and a commentary on “Association of sleep disturbances with geriatric age in atopic dermatitis patients”
- Pages e77-e78.
- Jelousi, Sami, BS, and Butler, Daniel C., MD.
- PDF
88. Circulation, sensation, and hair growth: A reply
- Pages e79-e79.
- Cavanagh, Gregory, BS, Goren, Andy, MD, and Wambier, Carlos Gustavo, MD, PhD.
- PDF
89. Comment on scalp neuropathy in androgenetic alopecia
- Pages e81-e81.
- Trüeb, Ralph M., MD, and Luu, Ngoc-Nhi C., MD.
- PDF
90. Shifting focus from “what we do” to the “impact of what we do”: Application of outcome measures to routine clinical care in dermatology
- Pages e83-e84.
- Garg, Amit, MD, Dirr, McKenzie A., BA, BS, Jemec, Gregor B.E., MD, DMSc, Ingram, John R., DM, FRCP, Schmitt, Jochen, MD, MPH, Spuls, Phyllis, MD, PhD, and Alam, Murad, MD, MSCI, MBA.
- PDF
91. Sample CME manuscript submission: Response to the article by Pham et al entitled “Review BRAF inhibition and the spectrum of granulomatous reactions”
- Pages e85-e88.
- Marcaillou, Marion, MD, Dion, Jeremie, MD, Baroudjian, Barouyr, MD, Ezrine, Emilien, MD, Carrera, Cristina, PhD, Anderle, Alisa, MD, Apalla, Zoe, PhD, Freites-Martinez, Azael, MD, Pages, Cécile, MD, Lebbe, Celeste, PhD, Meyer, Nicolas, PhD, Sibaud, Vincent, MD, and Comont, Thibault, MD.
- PDF
92. Reply to “Vitamin D status in scarring and nonscarring alopecia”
- Pages e89-e90.
- Afvari, Shawn, BS, Kazlouskaya, Maryia, MS, and Cline, Abigail, MD, PhD.
- PDF